Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 6 of 6 entries
View as:

Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection

Phase: N/A Priority: Normal
NCT ID: NCT03239223 Org: User:
Start: 01/01/18 End: 10/30/18 Due: 10/30/19

Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts

Phase: N/A Priority: Normal
NCT ID: NCT06491446 Org: User:
Start: 03/27/24 End: 02/28/26 Due: 02/28/27

A Study of ABI-2280 Vaginal Insert (Previously Referred to as ABI-2280 Vaginal Tablet) in Participants With Cervical Intraepithelial Neoplasia

Phase: N/A Priority: Normal
NCT ID: NCT05502367 Org: User:
Start: 09/10/22 End: 06/30/25 Due: 06/30/26

Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection.

Phase: N/A Priority: Normal
NCT ID: NCT03697226 Org: User:
Start: 12/21/18 End: 06/12/20 Due: 06/12/21

Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection

Phase: N/A Priority: Normal
NCT ID: NCT03202992 Org: User:
Start: 08/11/17 End: 02/04/19 Due: 02/04/20

Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection

Phase: N/A Priority: Normal
NCT ID: NCT03677960 Org: User:
Start: 12/17/18 End: 06/30/19 Due: 06/30/20